New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
PetMed Express, Inc.
PETS
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

80M

Medical - Pharmaceuticals

Next Earning date - 04 Nov 2024

80M

Medical - Pharmaceuticals

Next Earning date - 04 Nov 2024

3.89USD
Shape-0.24 ( -5.81%)
favorite-chart

Relative Strenght

10
favorite-chart

Volume Buzz

-4%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

63%

Quote Panel

Shape
Updated October 6, 2024
1W 5.71 % 1M 18.60 % 3M 1.04 % 1Y -60.67 %

Key Metrics

Shape
  • Market Cap

    80.14M


  • Shares Outstanding

    20.60M


  • Share in Float

    19.89M


  • Dividende

    0


  • Earning Date

    04 Nov 2024


  • Price Target

    3.89


  • Average Volume

    237470


  • Beta

    0.713


  • Range

    2.9-10.6


  • Industry

    Medical - Pharmaceuticals


  • Website

    https://www.1800petmeds.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.30x

P/S Ratio

0.85x

P/B Ratio

0.0

Debt/Equity

-1.2%

Net Margin

$-0.1

EPS

How PETS compares to sector?

P/E Ratio

Relative Strength

Shape

PETS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$266M

Shape291%

2025-Revenue

$0.09

Shape-53%

2025-EPS

$19M

Shape213%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Lake Street

downgrade

Previous: Buy

2024-08-07

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-58%

0.13
vs 0.31

Q4.22

arrow
arrow

-90%

0.02
vs 0.21

Q1.23

arrow
arrow

-87%

0.04
vs 0.3

Q2.23

arrow
arrow

N/A

-0.04
vs 0.14

Q3.23

arrow
arrow

N/A

-0.00
vs 0.13

Q4.23

arrow
arrow

N/A

0.02
vs 0.02

Q1.24

arrow
arrow

N/A

-0.25
vs 0.04

Q2.24

arrow
arrow

+550%

0.18
vs -0.04

Q3.24

arrow
arrow

N/A

-0.06
vs -0.00

Q4.24

arrow
arrow

N/A

-0.01
vs 0.02

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-3%

65.4M  vs 67.4M

Q4.22

arrow
arrow

-3%

58.9M  vs 60.7M

Q1.23

arrow
arrow

-5%

62.4M  vs 66M

Q2.23

arrow
arrow

+11%

78.2M  vs 70.2M

Q3.23

arrow
arrow

+9%

71M  vs 65.4M

Q4.23

arrow
arrow

+11%

65.3M  vs 58.9M

Q1.24

arrow
arrow

+7%

66.5M  vs 62.4M

Q2.24

arrow
arrow

-13%

68M  vs 78.2M

Q3.24

arrow
arrow

-7%

66M  vs 71M

Q4.24

arrow
arrow

0%

65M  vs 65.3M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+2%

0.02
vs 0.02

Q4.22

arrow
arrow

0%

-0.00
vs 0.02

Q1.23

arrow
arrow

-4%

-0.04
vs -0.00

Q2.23

arrow
arrow

-1%

-0.01
vs -0.04

Q3.23

arrow
arrow

0%

-0.00
vs -0.01

Q4.23

arrow
arrow

-2%

-0.02
vs -0.00

Q1.24

arrow
arrow

-5%

-0.05
vs -0.02

Q2.24

arrow
arrow

+4%

0.04
vs -0.05

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

183

183
vs 185

-1%

Q4.22

arrow
arrow

170

170
vs 183

-7%

Q1.23

arrow
arrow

173

173
vs 170

2%

Q2.23

arrow
arrow

161

161
vs 173

-7%

Q3.23

arrow
arrow

155

155
vs 161

-4%

Q4.23

arrow
arrow

139

139
vs 155

-10%

Q1.24

arrow
arrow

122

122
vs 139

-12%

Q2.24

arrow
arrow

117

117
vs 122

-4%

Earnings Growth

Latest News